Plastic recycling can provide environmental benefits by avoiding the detrimental impacts of alternative disposal pathways and enabling the substitution of primary materials. However, most studies aiming at increasing recycling rates have not investigated how the resulting secondary materials can be utilized in product manufacturing. This study assesses the future substitution potential of primary with secondary plastics, building on a material flow system of 11 plastic types in 54 product subsegments in Switzerland in 2017 with a recycling rate of 9%. In a prospective material flow analysis of a scenario for 2025, the collection rate of the plastic fractions collected in 2017 is increased to 80%. The secondary material flows are allocated to suitable uptaking product subsegments using a linear optimization. The maximum share of secondary materials utilizable in each product subsegment is estimated, whereby three sub-scenarios involving high, moderate and low allowed secondary material shares are modelled. Depending on plastic type and scenario, 21% to 100% of the secondary material gained can substitute for primary material, covering 11% to 17% of the total material demand. While the overall recycling rate could reach 23%, taking into account only the uptaken secondary materials a true recycling rate of only 17% results in the moderate applicability sub-scenario. Based on these results, the secondary material uptake can be said to constitute a limiting factor for increased future recycling. Therefore, thorough consideration of the possible secondary material application is a prerequisite for designing and assessing future recycling systems or for setting recycling rate targets.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.wasman.2022.01.002 | DOI Listing |
Depress Anxiety
January 2025
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Background: Individuals with mental health disorders face major barriers in accessing smoking cessation care, often due to the stigmas associated with mental disorders and addiction. Consequently, accessible population-based smoking cessation interventions are needed for this vulnerable group.
Objective: This secondary analysis utilized data from a 12-month randomized trial to examine whether an acceptance and commitment therapy-based app (iCanQuit) demonstrated greater efficacy, engagement, and satisfaction compared to a United States (US) Clinical Practice Guidelines-based app (QuitGuide) in helping adults with mental health disorders quit smoking.
Brain Spine
December 2024
Division of Neurosurgery, Department of Clinical Neurosciences, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.
Introduction: and research question: Prognostic factors to predict the behavior of pituitary neuroendocrine tumors (PitNET) are scarce. PD-L1 expression was associated with prognosis in other neuroendocrine neoplasms and we analyzed PD-L1 expression in PitNET, according to the 2022 WHO classification.
Material And Methods: A retrospective analysis was performed.
Neurosurg Focus Video
January 2025
Department of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; and.
Surgery of lesions around Wernicke's area is challenging for several reasons. The anatomical boundaries are not clearly defined, necessitating functional identification in addition to anatomical landmarks. There are potential complications secondary to injury of the surrounding structures.
View Article and Find Full Text PDFSurg Pract Sci
December 2022
Department of Surgery, University of the Witwatersrand, Johannesburg, South Africa.
Introduction: Trauma to the head and neck results in acute facial trauma and swelling, which may occlude the airway and result in fatal hypoxia. The management is the establishment of a definitive airway. This paper reviews our experience with this clinical scenario.
View Article and Find Full Text PDFF1000Res
January 2025
German Center for Mental Health (DZPG), partner site München/Augsburg, Munich, Germany.
Background: Muscarinic receptor agonism and positive allosteric modulation is a promising mechanism of action for treating psychosis, not present in most D2R-blocking antipsychotics. Xanomeline, an M1/M4-preferring agonist, has shown efficacy in late-stage clinical trials, with more compounds being investigated. Therefore, we aim to synthesize evidence on the preclinical efficacy of muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis to provide unique insights and evidence-based information to guide drug development.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!